<DOC>
	<DOCNO>NCT00955253</DOCNO>
	<brief_summary>To find spatial neglect follow stroke brain injury reduce use guanfacine , drug show improve neglect two stroke patient previous pilot study ( Malhotra et al , 2006 ) . In trial , effect guanfacine examine large number patient , also systematic assessment whether drug effective patient particular pattern brain damage .</brief_summary>
	<brief_title>Guanfacine Treatment Spatial Neglect Impaired Vigilance</brief_title>
	<detailed_description>The current study double-blind crossover design patient receive single 2mg dose oral guanfacine single dose placebo . They receive one Day 2 study period Day 4 . They test daily Days 1 5 test repetition long-term drug effect gauge . On day 2 4 test twice-once prior drug/placebo administration 90 minute drug/placebo administration . Tests include standard pen-and-paper task neglect well computerised test sustain attention visual exploration . In publish pilot study ( Malhotra et al , 2006 ) suggestion patient without damage frontal cortex likely respond guanfacine . In current study intend test 10 patient 10 patient without frontal damage order test .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Perceptual Disorders</mesh_term>
	<mesh_term>Guanfacine</mesh_term>
	<criteria>Age 18 Greater 2 week follow stroke Ability give consent Evidence robust Visual Neglect test twice cancellation task . Less 2 week follow stroke Concomitant illness may affect interpretation finding Labile blood pressure follow stroke Systolic BP le 100 mmHg / diastolic le 70 mmHg New antihypertensive medication start within last 3 week Patients hepatic renal dysfunction Patients receive medication know potentiate guanfacine 's antihypertensive hypotensive effect cause torsade de pointes , specifically antipsychotic ( include sultopride , chlorpromazine , thioridazine , amisulpiride , sulpiride , haloperidol ) , moxifloxacin , baclofen , verapamil , quinidine , hydroquinidine , dispyramide , amiodarone , dofetilide , ibutilide , sotalol , pimozide , bepridil , cisapride , diphemanil , erythromycin IV , halofantrine , pentamidine , sparfloxacin , vincamine , alfuzosin , prazosin , terazosin , tamsulosin , amifostine Patients diagnosis brain tumour Patients weight less 55kg Patients pregnant Mothers breast feeding Patients severe coronary insufficiency myocardial infarction previous 6 month Cognitive impairment , dysphasia dementia prevents patient give informed consent Severe mental impairment physical handicap follow stroke prevents patient give consent perform basic ( standard clinical ) test neglect</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Neglect</keyword>
	<keyword>Attention</keyword>
	<keyword>Vigilance</keyword>
	<keyword>Stroke</keyword>
	<keyword>Hemineglect</keyword>
	<keyword>Unilateral Neglect</keyword>
	<keyword>Spatial Neglect</keyword>
</DOC>